Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.20
Bid: 49.90
Ask: 50.20
Change: 1.60 (3.29%)
Spread: 0.30 (0.601%)
Open: 48.45
High: 51.10
Low: 47.20
Prev. Close: 48.60
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IP Group Net Asset Value Slides 6% As Portfolio Value Declines

Wed, 11th Mar 2020 09:04

(Alliance News) - IP Group PLC on Wednesday reported a drop in hard net asset value for 2019 due to a reduction in the fair value of its portfolio.

Also on Wednesday the London-based investor in technology companies announced that Non-Executive Director Jonathan Brooks has stepped down from his role with effect on Tuesday. Brooks has been in the role for nine years since 2011.

As at December 31, IP's hard net asset value per share 108 pence per share, down 6.1% from 115p on the same date a year before.

At the end of 2019, the group's fair value of its portfolio fell by 7.1% to GBP1.05 billion from GBP1.13 billion the prior year, reflecting a drop in value from the Life Sciences and Multi-Sector portions of the portfolio.

As at December 31, IP's portfolio comprises 57 "focus companies" - which represents 87% of its value - and 75 other companies. During the year, the group exited its interest in 8 companies, realising GBP79.5 million in cash proceeds, up from GBP29.5 million in 2018.

IP's portfolio loss for 2019 narrowed to GBP43.9 million from GBP48.4 million, with the major detractors being Autifony Therapeutics Ltd, PsiOxus Therapeutics Ltd and Topivert Ltd.

Positive contributors included Ceres Power Holdings PLC on new product launches and development contracts, while medical analysis firm Oxford Nanopore Technologies Ltd reported a robust 2018, leading to expansion in 2019.

"During 2019 the group's portfolio saw a net fair value reduction of GBP43.9 million or 4%, and, whilst disappointing, this reflects ongoing rationalisation in the portfolio and significant headwinds, particularly in the UK market. However, our three most valuable holdings, Oxford Nanopore, Istesso and Ceres Power, made excellent progress during the year with Oxford Nanopore and Ceres Power also announcing positive developments since the year end," said Chief Executive Alan Aubrey.

"Consequently, we remain confident in the prospects of our portfolio, which we continue to believe includes world-changing businesses that will deliver impact and significant benefits for multiple stakeholders," Aubrey added.

Shares in IP Group were up 1.5% at 59.35 pence on Wednesday in London.

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Mar 2021 12:22

Buybacks make a comeback as crisis eases

(Sharecast News) - UK companies have announced more than £2bn of share buybacks in 2021 with more in the pipeline, suggesting this means of returning cash to shareholders is on the way back.

Read more
10 Mar 2021 09:43

IP Group to pay maiden final 2020 dividend due to "successful" year

IP Group to pay maiden final 2020 dividend due to "successful" year

Read more
3 Mar 2021 16:24

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
3 Mar 2021 09:48

BROKER RATINGS: SocGen starts United Utilities and Pennon with Buy

BROKER RATINGS: SocGen starts United Utilities and Pennon with Buy

Read more
22 Feb 2021 09:44

BROKER RATINGS: Bank Of America Says Buy Aviva; Peel Cuts Fuller's

BROKER RATINGS: Bank Of America Says Buy Aviva; Peel Cuts Fuller's

Read more
19 Feb 2021 09:44

BROKER RATINGS: Investec Raises Hays, Cuts Senior And Paypoint

BROKER RATINGS: Investec Raises Hays, Cuts Senior And Paypoint

Read more
17 Feb 2021 08:57

IP Group Notes Centessa Pharma Launch Following ApcinteX Sale

IP Group Notes Centessa Pharma Launch Following ApcinteX Sale

Read more
10 Feb 2021 09:20

IP Group Says US Platform Secures Additional USD50 Million Of Funding

IP Group Says US Platform Secures Additional USD50 Million Of Funding

Read more
10 Feb 2021 08:45

IP Group's North American platform raises another $50m

(Sharecast News) - Intellectual property-based business developer IP Group announced on Wednesday that its North American platform, IP Group, Inc., has secured an additional $50m (£36.5m) of funding, including $40m from a new US blue-chip institutional investor.

Read more
7 Jan 2021 08:18

IP Group slumps as Invesco sells 61.9m shares

(Sharecast News) - IP Group slid on Thursday after Invesco sold 61.9m shares in the company in a placing.

Read more
6 Jan 2021 19:10

IN BRIEF: IP Group's Hinge Health Completes Funding Round

IN BRIEF: IP Group's Hinge Health Completes Funding Round

Read more
6 Jan 2021 10:49

UK WINNERS & LOSERS SUMMARY: Greggs Tops 250s Despite Profit Caution

UK WINNERS & LOSERS SUMMARY: Greggs Tops 250s Despite Profit Caution

Read more
6 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Berenberg Raises Vodafone To Buy

UK BROKER RATINGS SUMMARY: Berenberg Raises Vodafone To Buy

Read more
6 Jan 2021 09:07

IP Group Invests GBP4.0 Million In Oxbotica Series B Funding Round

IP Group Invests GBP4.0 Million In Oxbotica Series B Funding Round

Read more
6 Jan 2021 08:25

IP Group's Oxbiotica raises £36m in series B round

(Sharecast News) - Intellectual property investor IP Group announced on Wednesday that its autonomous vehicle software portfolio company Oxbotica has raised £36m of new capital in a series B round, from both new and existing investors.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.